Premaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time. The Company operates in the United Kingdom and Rest of the World.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:NIPT
- CUSIP: N/A
- Web: N/A
- Market Cap: £24.24 million
- Outstanding Shares: 228,163,000
- 50 Day Moving Avg: GBX 10.46
- 200 Day Moving Avg: GBX 9.63
- 52 Week Range: GBX 7 - GBX 14.40
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.000
- Annual Revenue: £3.28 million
- Price / Sales: 7.39
- Book Value: GBX (0.01) per share
- Price / Book: -17.71
- Average Volume: 619,842 shs.
Frequently Asked Questions for Premaitha Health PLC (LON:NIPT)
What is Premaitha Health PLC's stock symbol?
Premaitha Health PLC trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."
Where is Premaitha Health PLC's stock going? Where will Premaitha Health PLC's stock price be in 2017?
1 equities research analysts have issued 1-year price objectives for Premaitha Health PLC's stock. Their predictions range from GBX 18 to GBX 24. On average, they anticipate Premaitha Health PLC's share price to reach GBX 21 in the next twelve months. View Analyst Ratings for Premaitha Health PLC.
Who are some of Premaitha Health PLC's key competitors?
Some companies that are related to Premaitha Health PLC include Rambler Metals and Mining PLC (RMM), Seeing Machines Limited (SEE), Bushveld Minerals Limited (BMN), Applied Graphene Materials PLC (AGM), Bonmarche Holdings PLC (BON), Wolf Minerals Limited (WLFE), Watchstone Group PLC (QPP), Atlantis Resources Ltd (ARL), Management Consulting Group PLC (MMC), Kromek Group PLC (KMK), Sanderson Group plc (SND), Cerillion PLC (CER), Wentworth Resources Ltd (WRL), Waterman Group plc (WTM), Taptica International Ltd (MARI), Plant Health Care plc (PHC), Beowulf Mining plc (BEM) and Trans-Siberian Gold plc (TSG).
How do I buy Premaitha Health PLC stock?
Shares of Premaitha Health PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Premaitha Health PLC stock cost?
One share of Premaitha Health PLC stock can currently be purchased for approximately GBX 10.63.
Consensus Ratings for Premaitha Health PLC (LON:NIPT) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 21|
Analysts' Ratings History for Premaitha Health PLC (LON:NIPT)
(Data available from 5/26/2015 forward)
|7/4/2016||Panmure Gordon||Reiterated Rating||Buy||GBX 24|
Earnings History for Premaitha Health PLC (LON:NIPT)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Premaitha Health PLC (LON:NIPT)
Current Year EPS Consensus Estimate: $-2.340 EPS
Dividend History for Premaitha Health PLC (LON:NIPT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Premaitha Health PLC (LON:NIPT)Insider Trades by Quarter for Premaitha Health PLC (LON:NIPT)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/17/2015||Hextall,Barry Kenneth||Insider||Buy||180,736||GBX 18||£32,532.48|
Headline Trends for Premaitha Health PLC (LON:NIPT)
Latest Headlines for Premaitha Health PLC (LON:NIPT)
Premaitha Health PLC (NIPT) Chart for Friday, May, 26, 2017